Production (Stage)
Precigen, Inc.
PGEN
$1.33
$0.000.00%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 4.15M | 3.89M | 3.94M | 4.36M | 5.42M |
Total Other Revenue | 48.00K | 33.00K | 25.00K | 25.00K | 17.00K |
Total Revenue | 4.20M | 3.93M | 3.96M | 4.39M | 5.44M |
Cost of Revenue | 73.06M | 73.03M | 68.76M | 69.29M | 66.16M |
Gross Profit | -68.85M | -69.11M | -64.80M | -64.90M | -60.72M |
SG&A Expenses | 43.50M | 41.29M | 40.56M | 39.92M | 38.93M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 97.09M | 98.63M | 99.32M | 99.42M | 95.30M |
Operating Income | -92.89M | -94.71M | -95.36M | -95.03M | -89.86M |
Income Before Tax | -158.41M | -128.03M | -141.60M | -137.44M | -97.34M |
Income Tax Expenses | -1.76M | -1.79M | -2.04M | -2.06M | -432.00K |
Earnings from Continuing Operations | -156.65 | -126.24 | -139.56 | -135.38 | -96.91 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -156.65M | -126.24M | -139.56M | -135.38M | -96.91M |
EBIT | -92.89M | -94.71M | -95.36M | -95.03M | -89.86M |
EBITDA | -89.33M | -90.18M | -89.88M | -88.58M | -83.30M |
EPS Basic | -0.57 | -0.48 | -0.55 | -0.54 | -0.39 |
Normalized Basic EPS | -0.28 | -0.23 | -0.23 | -0.23 | -0.22 |
EPS Diluted | -0.57 | -0.48 | -0.55 | -0.54 | -0.39 |
Normalized Diluted EPS | -0.28 | -0.23 | -0.23 | -0.23 | -0.22 |
Average Basic Shares Outstanding | 1.12B | 1.07B | 1.03B | 999.03M | 994.66M |
Average Diluted Shares Outstanding | 1.12B | 1.07B | 1.03B | 999.03M | 994.66M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |